Krainer M - Search Results

1

Targeting signaling pathways in ovarian cancer.

Reibenwein J, Krainer M. Reibenwein J, et al. Among authors: krainer m. Expert Opin Ther Targets. 2008 Mar;12(3):353-65. doi: 10.1517/14728222.12.3.353. Expert Opin Ther Targets. 2008. PMID: 18269344 Review.

2

Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.

Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M. Reibenwein J, et al. Among authors: krainer m. Prostate. 2007 Mar 1;67(4):427-32. doi: 10.1002/pros.20533. Prostate. 2007. PMID: 17192910

3

In ovarian cancer the prognostic influence of HER2/neu is not dependent on the CXCR4/SDF-1 signalling pathway.

Pils D, Pinter A, Reibenwein J, Alfanz A, Horak P, Schmid BC, Hefler L, Horvat R, Reinthaller A, Zeillinger R, Krainer M. Pils D, et al. Among authors: krainer m. Br J Cancer. 2007 Feb 12;96(3):485-91. doi: 10.1038/sj.bjc.6603581. Epub 2007 Jan 23. Br J Cancer. 2007. PMID: 17245339 Free PMC article.

4

A prospective, open label, randomized phase II trial of weekly docetaxel versus weekly vinorelbine as first line chemotherapy in patients with androgen independent prostate cancer.

Krainer M, Tomek S, Elandt K, Horak P, Albrecht W, Eisenmenger M, Höltl W, Schramek P, Stackl W, Zielinski C, Reibenwein J. Krainer M, et al. J Urol. 2007 Jun;177(6):2141-5; discussion 2145. doi: 10.1016/j.juro.2007.01.148. J Urol. 2007. PMID: 17509302 Clinical Trial.

5

Natural immunity enhances the activity of a DR5 agonistic antibody and carboplatin in the treatment of ovarian cancer.

El-Gazzar A, Perco P, Eckelhart E, Anees M, Sexl V, Mayer B, Liu Y, Mikulits W, Horvat R, Pangerl T, Zheng D, Krainer M. El-Gazzar A, et al. Among authors: krainer m. Mol Cancer Ther. 2010 Apr;9(4):1007-18. doi: 10.1158/1535-7163.MCT-09-0933. Epub 2010 Apr 6. Mol Cancer Ther. 2010. PMID: 20371719

6

hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.

Wittinger M, Vanhara P, El-Gazzar A, Savarese-Brenner B, Pils D, Anees M, Grunt TW, Sibilia M, Holcmann M, Horvat R, Schemper M, Zeillinger R, Schöfer C, Dolznig H, Horak P, Krainer M. Wittinger M, et al. Among authors: krainer m. Clin Cancer Res. 2011 Dec 15;17(24):7816-27. doi: 10.1158/1078-0432.CCR-11-0408. Epub 2011 Oct 20. Clin Cancer Res. 2011. PMID: 22016507

7

Synthetic lethality guiding selection of drug combinations in ovarian cancer.

Heinzel A, Marhold M, Mayer P, Schwarz M, Tomasich E, Lukas A, Krainer M, Perco P. Heinzel A, et al. Among authors: krainer m. PLoS One. 2019 Jan 25;14(1):e0210859. doi: 10.1371/journal.pone.0210859. eCollection 2019. PLoS One. 2019. PMID: 30682083 Free PMC article.

8

Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.

Tong D, Volm T, Eberhardt E, Krainer M, Leodolter S, Kreienberg R, Zeillinger R. Tong D, et al. Among authors: krainer m. Oncol Rep. 2003 Sep-Oct;10(5):1551-3. Oncol Rep. 2003. PMID: 12883740

9

Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancer.

Köstler WJ, Steger GG, Soleiman A, Schwab B, Singer CF, Tomek S, Brodowicz T, Krainer M, Wiltschke C, Horvat R, Jakesz R, Zielinski CC. Köstler WJ, et al. Among authors: krainer m. Anticancer Res. 2004 Mar-Apr;24(2C):1127-30. Anticancer Res. 2004. PMID: 15154635 Free article.

10

Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.

Tomek S, Horak P, Pribill I, Haller G, Rössler M, Zielinski CC, Pils D, Krainer M. Tomek S, et al. Among authors: krainer m. Gynecol Oncol. 2004 Jul;94(1):107-14. doi: 10.1016/j.ygyno.2004.04.012. Gynecol Oncol. 2004. PMID: 15262127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page